








The document discusses proton pump inhibitors (PPIs) which inhibit gastric acid secretion by blocking the hydrogen-potassium ATPase pump in the stomach. PPIs are converted to sulfoxide derivatives that covalently bind to cysteine residues on the pump, preventing it from pumping protons into the stomach lumen. Common PPIs mentioned are omeprazole, pantoprazole, rabeprazole, and lansoprazole. Each drug is used to treat various acid-related gastrointestinal conditions such as heartburn, GERD, and ulcers. The mechanism of action involves the covalent inhibition of the proton pump through binding of activated PPIs to the pump.








